Cargando…

313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections

BACKGROUND: There are several clinical tools for prediction of antimicrobial resistance. However, their utility in management of bloodstream infections (BSI) due to resistant bacteria remains unclear. This quasi-experimental cohort examined the impact of utilization of the extended-spectrum beta-lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDougal, Elizabeth, Justo, Julie Ann, Kohn, Joseph, Bookstaver, P B, Winders, Hana R, Al-hasan, Majdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777903/ http://dx.doi.org/10.1093/ofid/ofaa439.356

Ejemplares similares

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)

290. Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections
por: Amipara, Rajiv G, et al.
Publicado: (2020)

Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection
por: Amipara, Rajiv, et al.
Publicado: (2021)

Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
por: Al-Hasan, Majdi N., et al.
Publicado: (2019)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection
por: Elizabeth. Battle, Sarah, et al.
Publicado: (2019)

Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)
por: Winders, Hana R., et al.
Publicado: (2022)

122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection
por: Powers, Caroline, et al.
Publicado: (2019)

Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System
por: Shealy, Stephanie, et al.
Publicado: (2021)

Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
por: Foster, Rachel A., et al.
Publicado: (2019)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

243. Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina
por: Winders, Hana R, et al.
Publicado: (2020)

1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
por: Pizzuti, Morgan, et al.
Publicado: (2021)

Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study
por: Winders, Hana R., et al.
Publicado: (2021)

Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report
por: Jones, Jordan, et al.
Publicado: (2022)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
por: Shealy, Stephanie C., et al.
Publicado: (2020)

The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China
por: Zou, Dongna, et al.
Publicado: (2021)

Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute Pyelonephritis
por: Pizzuti, Morgan, et al.
Publicado: (2023)

Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy
por: Carlisle, Leah, et al.
Publicado: (2018)

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales
por: Mathers, Amy J, et al.
Publicado: (2021)

44. Cost Effectiveness and Clinical Outcomes of Long Acting Lipoglycopeptides Used in Transitions of Care for Deep-Seated Infections
por: Antosz, Kayla S, et al.
Publicado: (2021)

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

1839. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia
por: Steere, Evan, et al.
Publicado: (2022)

1843. Intravenous versus Partial Oral Antibiotic Therapy in the Treatment of Uncomplicated Bloodstream Infection due to Streptococcus species
por: Broermann, Lynn, et al.
Publicado: (2022)

Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care
por: Antosz, Kayla, et al.
Publicado: (2021)

Intravenous versus Partial Oral Antibiotic Therapy in the Treatment of Uncomplicated Bloodstream Infection Due to Streptococcus Species
por: Broermann, Lynn E., et al.
Publicado: (2023)

2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices
por: Hamlin, Kelsey D, et al.
Publicado: (2023)

Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
por: Al-Hasan, Majdi N.
Publicado: (2020)

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales
por: Paterson, David L, et al.
Publicado: (2021)

Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021)

Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa
por: Pulford, Caisey V., et al.
Publicado: (2020)

2733. Association Between Influenza Vaccination Coverage and Ambulatory Antibiotic Prescription Rates in Children in South Carolina
por: Younas, Mariam, et al.
Publicado: (2019)

Antimicrobial Resistance in Enterobacterales Bacilli Isolated from Bloodstream Infection in Surgical Patients of Polish Hospitals
por: Kłos, M., et al.
Publicado: (2021)

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States
por: Tamma, Pranita D, et al.
Publicado: (2019)

Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system
por: O’Neal, Melissa, et al.
Publicado: (2020)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections
por: Mackow, Natalie A, et al.
Publicado: (2023)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_euqfnkef785keaigvgv0i1h8pm